QUETIAPINE (has an active metabolite) | QUETIAPINE | ATC N05AH04
NERVOUS SYSTEM ANTIPSYCHOTIC SCHIZOPHRENIA DIBENZOTHIAZEPINE FAMILY DOPAMINE D2 RECEPTOR ANTAGONIST (IC50=329 NANOMOLAR) SEROTONIN (5HT2) ANTAGONIST (IC50=148 NANOMOLAR) SEROTONIN 5HT1A ANTAGONIST (IC50=717 NANOMOLAR) DOPAMINE D1 ANTAGONIST (IC50=1268 NANOMOLAR) HISTAMINE H1 ANTAGONIST (IC50=30 NANOMOLAR) ADRENERGIC ALPHA 1 RECEPTOR ANTAGONIST (IC50= 94 NANOMOLAR) ADRENARGIC ALPHA 2 RECEPTOR ANTAGONIST (IC50=271 NANOMOLAR) NO APPRECIABLE AFFINITY AT CHOLINERGIC MUSCARINIC AND BENZODIAZEPINE RECEPTORS (IC50 SUPERIOR TO 5000 NANOMOLAR) | ORAL | F 100 PERCENT VD 650 LITER (65 KILOGRAM) PPB 83 PERCENT Cl 75 LITER / HOUR (EQN) HT 6 HOUR SOLUBILITY MODERATELY SOLUBLE IN WATER | 5-HYDROXYTRYPTAMINE 2 RECEPTOR D2 DOPAMINE RECEPTOR | DOPAMINE D2 RECEPTOR ANTAGONIST CHEMBL217 DOPAMINE D2 RECEPTOR P14416 D(2) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |